The first step in reverse cholesterol transport is interaction of apolipoprotein A-l (apoA-l) with the ATP-binding cassette A1 (ABCA1) transporter, which is responsible for facilitating the transport and efflux of cholesterol from cells to form high density lipoprotein (HDL). Studies have indicated that ABCA1 preferentially transports low density lipoprotein (LDL)-derived cholesterol from late endosomes/lysosomes, a process that is regulated by the sterol-sensing Niemann-Pick C1 (NPC1) protein. It has been determined that other sterol-sensing proteins are negatively modulated by an insulin-inducible gene product called lnsig-1, however it remains unknown whether NPC1 is modulated in a similar fashion. The objective of this application is to determine the molecular basis for decreased apoA-l mediated cholesterol transport and efflux facilitated by ABCA1 when LDL-derived cholesterol-enriched human fibroblasts are incubated in the presence of increased insulin. The central hypotheses for this application is that increased insulin promotes lnsig-1 to negatively modulate NPC1, thereby causing inhibition of cholesterol transport and efflux from late endosomes/lysosomes facilitated by ABCA1. The rationale for conducting the proposed research is supported by studies indicating that lnsig-1 modulates the function of other sterol-sensing proteins by promoting retention at the endoplasmic reticulum, and that NPC1 transiently interacts with late endosomes/lysosomes and the endoplasmic reticulum. To test our central hypothesis and accomplish the objectives of this application, we propose the following specific aims.
Specific Aim 1 : Determine the expression of ABCA1, NPC1, and lnsig-1 resulting from the incubation of LDL-derived cholesterol-enriched human fibroblasts in the presence of low and high insulin.
Specific Aim 2 : Determine the cellular distribution and interaction of ABCA1, NPC1, and lnsig-1 resulting from the incubation of LDL-derived cholesterol-enriched human fibroblasts in the presence of low and high insulin.
Specific Aim 3 : Determine the transport of cholesterol into lipid rafts resulting from incubation of LDL-derived cholesterol-enriched human fibroblasts in the presence of low and high insulin. The proposed studies will have a significant impact on determining the mechanism of insulin resistance and/or hyperinsulinemia in causing premature ACVD and decreased HDL cholesterol with concomitant accumulation of cholesterol in cells of the artery wall. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21DK071544-01
Application #
6954887
Study Section
Special Emphasis Panel (ZRG1-DIG-C (02))
Program Officer
Haft, Carol R
Project Start
2005-07-01
Project End
2007-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
1
Fiscal Year
2005
Total Cost
$188,125
Indirect Cost
Name
University of Arizona
Department
Pediatrics
Type
Schools of Medicine
DUNS #
806345617
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Jelinek, David; Castillo, Joseph J; Heidenreich, Randall A et al. (2015) The C57BL/6J Niemann-Pick C1 mouse model with decreased gene dosage is susceptible to increased weight gain when fed a high-fat diet: Confirmation of a gene-diet interaction. Gene 568:112-3
Jelinek, David; Heidenreich, Randy A; Orlando, Robert A et al. (2014) The Niemann-Pick C1 and caveolin-1 proteins interact to modulate efflux of low density lipoprotein-derived cholesterol from late endocytic compartments. J Mol Biochem 3:14-26
Jelinek, David; Castillo, Joseph J; Richardson, Lisa M et al. (2012) The Niemann-Pick C1 gene is downregulated in livers of C57BL/6J mice by dietary fatty acids, but not dietary cholesterol, through feedback inhibition of the SREBP pathway. J Nutr 142:1935-42
Garver, William S (2011) Gene-diet interactions in childhood obesity. Curr Genomics 12:180-9
Jelinek, David; Millward, Veronica; Birdi, Amandip et al. (2011) Npc1 haploinsufficiency promotes weight gain and metabolic features associated with insulin resistance. Hum Mol Genet 20:312-21
Garver, William S; Jelinek, David; Meaney, F John et al. (2010) The National Niemann-Pick Type C1 Disease Database: correlation of lipid profiles, mutations, and biochemical phenotypes. J Lipid Res 51:406-15
Jelinek, David; Heidenreich, Randall A; Erickson, Robert P et al. (2010) Decreased Npc1 gene dosage in mice is associated with weight gain. Obesity (Silver Spring) 18:1457-9
Jelinek, David; Patrick, Sarah Mount; Kitt, Khameeka N et al. (2009) Physiological and coordinate downregulation of the NPC1 and NPC2 genes are associated with the sequestration of LDL-derived cholesterol within endocytic compartments. J Cell Biochem 108:1102-16
Garver, William S; Jelinek, David; Francis, Gordon A et al. (2008) The Niemann-Pick C1 gene is downregulated by feedback inhibition of the SREBP pathway in human fibroblasts. J Lipid Res 49:1090-102
Garver, William S; Francis, Gordon A; Jelinek, David et al. (2007) The National Niemann-Pick C1 disease database: report of clinical features and health problems. Am J Med Genet A 143A:1204-11

Showing the most recent 10 out of 11 publications